MedTrace Logo

Parenteral Nutrition With Intravenous and Oral Fish Oil for Intensive Care Patients

NCT01162928 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-04-27

No results posted yet for this study

Summary

The primary objective is to assess the effect of fish oil-enriched enteral and parenteral nutrition on blood oxygenation in critically ill patients.

Conditions

  • Critical Illness

Interventions

DRUG

Nutriflex Omega special + Oxepa

3-chamber-bag combined with enteral nutrition

DRUG

Nutriflex Lipid special + Pulmocare

3-chamber-bag combined with enteral nutrition

Sponsors & Collaborators

  • B. Braun Melsungen AG

    lead INDUSTRY

Principal Investigators

  • Pierre Singer, MD · Rabin Medical Center, Beilinson Campus

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-05-31
Primary Completion
2017-11-30
Completion
2017-11-30

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01162928 on ClinicalTrials.gov